These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2854436)

  • 21. Multimodality management of regionally advanced non-small-cell lung cancer.
    Belani CP
    Semin Oncol; 1993 Aug; 20(4):302-14. PubMed ID: 8393590
    [No Abstract]   [Full Text] [Related]  

  • 22. [Concurrent chemoradiotherapy for stage III non-small cell lung cancer].
    Hou HL; Hao JL; Pang QS; Wang P
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(29):2068-70. PubMed ID: 21029648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined modality therapy in small cell lung cancer.
    Bunn P; Arriagada R; Choi N; Feld R; Gregor A; Jett J; Johnson B; Komaki R; Kristjansen P; Murray N
    Lung Cancer; 1994 Mar; 10 Suppl 1():S25-8. PubMed ID: 8087517
    [No Abstract]   [Full Text] [Related]  

  • 25. A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.
    Kim TY; Yang SH; Lee SH; Park YS; Im YH; Kang WK; Ha SH; Park CI; Heo DS; Bang YJ; Kim NK
    Am J Clin Oncol; 2002 Jun; 25(3):238-43. PubMed ID: 12040280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combined intra-arterial chemotherapy and radiotherapy in inoperable non-small cell bronchial carcinoma].
    Rieber A; Brambs HJ; Kauffmann G; Wannenmacher M; Drings P
    Strahlenther Onkol; 1991 Jan; 167(1):14-8. PubMed ID: 1846982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Split-course radiotherapy with or without concurrent or sequential chemotherapy in non-small cell lung cancer.
    Ulutin HC; Güden M; Oysul K; Sürenkök S; Pak Y
    Radiat Med; 2000; 18(2):93-6. PubMed ID: 10888041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.
    Keller SM; Adak S; Wagner H; Herskovic A; Komaki R; Brooks BJ; Perry MC; Livingston RB; Johnson DH
    N Engl J Med; 2000 Oct; 343(17):1217-22. PubMed ID: 11071672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined chemotherapy and radiation therapy for non-small-cell lung cancer.
    Osoba D; Rusthoven JJ; Evans WK; Turnbull KA
    Semin Oncol; 1986 Sep; 13(3 Suppl 3):121-4. PubMed ID: 2429368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [International consensus for lung cancer treatment].
    Naruse I; Saijo N
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():451-9. PubMed ID: 9369922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation chemotherapy in multimodality therapy of non-small cell lung cancer.
    Vokes EE
    Front Radiat Ther Oncol; 1992; 26():64-71. PubMed ID: 1324877
    [No Abstract]   [Full Text] [Related]  

  • 32. Preoperative combined modality therapy for stage III M0 non-small cell lung carcinoma.
    Pincus M; Reddy S; Lee MS; Bonomi P; Taylor S; Rowland K; Faber LP; Warren W; Kittle CF; Hendrickson FR
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):189-95. PubMed ID: 2839440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent cisplatin and etoposide with radiotherapy in locally advanced non-small cell lung cancer.
    Friess GG; Baikadi M; Harvey WH
    Cancer Treat Rep; 1987; 71(7-8):681-4. PubMed ID: 3038313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
    Tamura A; Mikami A; Sagara Y; Hebisawa A
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1755-8. PubMed ID: 11057330
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients.
    Ozcelik M; Korkmaz T; Odabas H; Gemici C; Ercelep O; Yuksel S; Mert AG; Surmeli H; Isik D; Aydin D; Seker M; Mayadagli A; Ozdemir P; Aliustaoglu M; Gumus M
    Tumour Biol; 2016 Jul; 37(7):8901-7. PubMed ID: 26753955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
    Rice TW; Adelstein DJ; Koka A; Tefft M; Kirby TJ; Van Kirk MA; Taylor ME; Olencki TE; Peereboom D; Budd GT
    Ann Thorac Surg; 1995 Sep; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M; Chapman R; Kim JH
    Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation-chemotherapy interactions in limited small cell lung cancer.
    Livingston RB
    Front Radiat Ther Oncol; 1992; 26():72-82. PubMed ID: 1324878
    [No Abstract]   [Full Text] [Related]  

  • 39. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F; Brewer Y; Vincent P; Chauvet B; Faure CF; Taulelle M
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):343-50. PubMed ID: 8635942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of therapy with etoposide, 5-fluorouracil by continuous infusion, cisplatin, and simultaneous split-course radiation in stage III non-small cell bronchogenic carcinoma.
    Bonomi P; Rowland KM; Taylor SG; Pincus M; Reddy S; Lee MS; Faber LP; Warren W; Kittle CF
    NCI Monogr; 1988; (6):331-4. PubMed ID: 2832768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.